DiSCIS Clinical Core
DiSCIS 临床核心
基本信息
- 批准号:8769788
- 负责人:
- 金额:$ 40.21万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAfrican AmericanAlabamaAppointmentBacterial VaginosisBehaviorBehavioralBiologicalChlamydia trachomatisClinicClinic VisitsClinicalClinical ResearchCollectionCommunicationConfidentialityCost SavingsCountyCouplesDataDiagnosisDiagnosticEmotionalEnrollmentEnsureEthicsEventFatigueFemaleFoundationsGoalsHealthHealthcareHigh PrevalenceHome environmentHourInterventionKnowledgeLaboratoriesMaintenanceNylonsOnline SystemsPaperParticipantPatient CarePatientsPerformancePlayPopulation StudyPreventionPrintingProceduresProtocols documentationQuestionnairesRecoveryRecruitment ActivityResearchResearch DesignResearch InfrastructureResearch PersonnelRoleScheduleSecureSex BehaviorSexual HealthSexual PartnersSexually Transmitted DiseasesSpecimenSymptomsSyndromeTelephoneTextTimeTrainingUniversitiesUrethritisUrineVaginaVisitWomanabstractingbasecohortdesigndiariesexperienceflexibilityfollow-uphigh standardhuman subjectmalemenpaymentprogramsprospectiveresearch studysample collectionscreeningsexsuccesstool
项目摘要
DiSCIS Clinical Core Abstract
The overarching goal of the Clinical Core is to engage, enroll, and retain participants in the Discharge
Syndromes: Concordance and Interactions Study (DiSCIS) application. The investigators recognize
the central role that human subjects play in this application and also the sensitivity of the information
collected from study participants. All researchers will adhere to the highest level of ethical behavior in
order to protect the physical and emotional wellbeing of the participants. The Clinical Core will
support all projects outlined in the proposal through recruitment and performance of all clinic visits,
including screening, initial, and subsequent study visits. Recruitment and all clinic events will be
centralized at the Jefferson County Department of Health (JCDH) STD Clinic. In 2012, 16,119
patients (males=7,360 and females=8,759) received sexual health care at the JCDH STD Clinic.
High prevalence of discharge syndromes including nongonococcal urethritis (about 25% of men),
bacterial vaginosis (about 50% of women), and Chlamydia trachomatis (about 12% overall) are
diagnosed and treated in this clinic. The JCDH STD Clinic and the University of Alabama (UAB) STD
Program have an enduring partnership in STI research and STI-related patient care and a strong
infrastructure already exists in this clinic for STI-related research. To maximize the success of the
Clinical Core, we have assembled a clinical team with experience in designing, performing and
completing longitudinal STI studies including couples studies. The specific aims for the Clinical Core
are: (1) To centralize recruitment of men and women in regular sexual partnerships to create a
cohort of participants to support all proposed projects, (2) To retain men and women in
regular sexual partnerships for the duration of the study period, and (3) To collect accurate
and complete participant information and biologics while protecting participant
confidentiality. By supporting Projects 1-3, the Clinical Core will help to create new knowledge,
advance diagnostic tools, and optimize therapy related to the most common discharge syndromes.
The Clinical Core and its tight linkage to the Laboratory Core will ensure collection of quality
specimens, efficiency and cost savings. The collective expertise of the Clinical Core team in clinical
research study design, participant recruitment, and participant retention in prospective STI research
including sexual dyad studies will provide a strong foundation for the success of all DiSCIS Projects
while adhering to the highest standards of clinical research.
DiSCIS 临床核心摘要
临床核心的总体目标是吸引、招募和留住出院参与者
综合症:一致性和相互作用研究 (DiSCIS) 应用。调查人员认识到
人类受试者在此应用中发挥的核心作用以及信息的敏感性
从研究参与者收集。所有研究人员都将遵守最高水平的道德行为
以保护参与者的身心健康。临床核心将
通过招募和进行所有诊所就诊来支持提案中概述的所有项目,
包括筛选、初次和随后的研究访视。招募和所有临床活动将在
集中在杰斐逊县卫生部 (JCDH) 性病诊所。 2012年,16,119
患者(男性 = 7,360 名,女性 = 8,759 名)在 JCDH STD 诊所接受性保健护理。
出院综合征的患病率很高,包括非淋菌性尿道炎(约 25% 的男性)、
细菌性阴道病(约占女性的 50%)和沙眼衣原体病(约占总体的 12%)
在此诊所进行诊断和治疗。 JCDH STD 诊所和阿拉巴马大学 (UAB) STD
该计划在性传播感染研究和性传播感染相关患者护理方面拥有持久的合作伙伴关系,并且拥有强大的实力
该诊所已经存在用于性传播感染相关研究的基础设施。为了最大限度地取得成功
临床核心,我们组建了一支在设计、执行和实施方面拥有丰富经验的临床团队。
完成纵向性传播感染研究,包括夫妻研究。临床核心的具体目标
是: (1) 集中招募具有定期性伙伴关系的男性和女性,以建立一个
支持所有拟议项目的参与者群体,(2) 留住男性和女性
在研究期间定期发生性关系,以及 (3) 收集准确的
并完整的参与者信息和生物制剂,同时保护参与者
保密性。通过支持项目 1-3,临床核心将有助于创造新知识、
先进的诊断工具,并优化与最常见的出院综合症相关的治疗。
临床核心及其与实验室核心的紧密联系将确保收集的质量
标本,提高效率并节省成本。临床核心团队在临床方面的集体专业知识
前瞻性性传播感染研究中的研究设计、参与者招募和参与者保留
包括性二元研究将为所有 DiSCIS 项目的成功提供坚实的基础
同时坚持临床研究的最高标准。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Nicholas J Van Wagoner其他文献
Nicholas J Van Wagoner的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Nicholas J Van Wagoner', 18)}}的其他基金
Inhibition of Herpes Simplex Virus Type 2 by Tenofovir
替诺福韦对 2 型单纯疱疹病毒的抑制作用
- 批准号:
8492027 - 财政年份:2012
- 资助金额:
$ 40.21万 - 项目类别:
Inhibition of Herpes Simplex Virus Type 2 by Tenofovir
替诺福韦对 2 型单纯疱疹病毒的抑制作用
- 批准号:
8223679 - 财政年份:2012
- 资助金额:
$ 40.21万 - 项目类别:
Inhibition of Herpes Simplex Virus Type 2 by Tenofovir
替诺福韦对 2 型单纯疱疹病毒的抑制作用
- 批准号:
9064072 - 财政年份:2012
- 资助金额:
$ 40.21万 - 项目类别:
Inhibition of Herpes Simplex Virus Type 2 by Tenofovir
替诺福韦对 2 型单纯疱疹病毒的抑制作用
- 批准号:
9064072 - 财政年份:2012
- 资助金额:
$ 40.21万 - 项目类别:
相似海外基金
Integrating Genomic Risk Assessment for Chronic Disease Management in a Diverse Population
整合基因组风险评估以进行不同人群的慢性病管理
- 批准号:
10852376 - 财政年份:2023
- 资助金额:
$ 40.21万 - 项目类别:
ENRICH ALABAMA: Improving cardiovascular health of women and children through a novel home visiting intervention
ENRICH ALABAMA:通过新颖的家访干预措施改善妇女和儿童的心血管健康
- 批准号:
10618316 - 财政年份:2022
- 资助金额:
$ 40.21万 - 项目类别:
ENRICH ALABAMA: Improving cardiovascular health of women and children through a novel home visiting intervention
ENRICH ALABAMA:通过新颖的家访干预措施改善妇女和儿童的心血管健康
- 批准号:
10426961 - 财政年份:2022
- 资助金额:
$ 40.21万 - 项目类别:
Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention
用于预防艾滋病毒的可接受的多用户可生物降解缓释 (AMBER) 植入系统
- 批准号:
10663830 - 财政年份:2020
- 资助金额:
$ 40.21万 - 项目类别:
Acceptable Multi-user Biodegradable Extended Release (AMBER) Implant System for HIV Prevention
用于预防艾滋病毒的可接受的多用户可生物降解缓释 (AMBER) 植入系统
- 批准号:
10064253 - 财政年份:2020
- 资助金额:
$ 40.21万 - 项目类别: